HER2 drugs for Biliary Tract Cancer
2 tracked HER2 drugs in the Biliary Tract Cancer race. The class explanation lives on the HER2 page; the full indication pipeline across every mechanism is on the Biliary Tract Cancer page.
1 approved / phase 41 Phase 3
Head-to-head evidence: Trastuzumab brengitecan vs Zanidatamab